Featured News

Wall Street

Adam Sarhan |

Stocks fell hard again last week as fear of a looming trade war between the U.S. and China grew.

Business Outlook

The conference was an amalgam of dozens of small businesses whose aim was to reduce environmental pollution and…

Life Sciences

30 million people - 15% of US adults - suffer from chronic kidney disease.


Cryptocurrencies are only the tip of the iceberg when it comes to the impact blockchain can have on…


The brick and mortar world has seen many decades of consolidation. The internet, while newer, is no stranger…


Education apps like Google Classroom could help students learn 21st century skills such as collaboration that they will…


Of these 7 strategies selected today 5 are Long, bullish in outlook. 2 are Short, bearish in outlook.


SPDR Gold Trust is an exchange-traded fund (ETF) that seeks to reflect the performance of the price of…


Our lives are quite busy these days. That said, it's common for them to feel off balance. Here's…


This can be a dangerous stock to buy at peak times.

Business Outlook

These questions aren’t really asked anymore.


As of now, cryptocurrencies are not protected by any central government or insurance provider. That said, it's up…


Comebacks are always in style; here are five stocks that struggled last year but are likely to rebound…


China has retaliated against Donald Trump’s decision to impose tariffs on steel and aluminium by signalling that it…


Milton “Todd” Ault III, the Company’s CEO and Chairman. “This new arrangement will allow SCM to build out…


Dropbox doesn't have a typical venture capital history.


Now that Facebook's true influence level has been unveiled, here are the potential drawbacks

Life Sciences

Median progression-free survival of 14.9 months using encorafenib and binimetinib together.


How can investors buy bitcoin in a way that can benefit from its price appreciation, but won’t lose…


Equities.com in partnership with Tradier Brokerage Inc. is pleased today to announce the availability of commission free &…

Alternative Investments

While craft breweries are traditionally small, there are a few that have grown to rival the big name…



Equities.com Spring Investor Wealth Conference @ PECLA

At the Equities.com premiere Investor Wealth Series, we are going to explore several exciting 2018 innovation and investment opportunities. The opportunities will allow you to obtain diversification through asset class…

Learn more

Emerging Growth

Immunovaccine Inc.

Immunovaccine Inc is clinical stage biopharmaceutical company. The Company develops products based on its proprietary vaccine enhancement platform in T cell activating therapies for cancer.

​Immunovaccine (IMMVF) Announces Year-End 2017 Financial Results

Immunovaccine Inc. (TSX:IMV) (OTCQX:IMMVF), a clinical stage immuno-oncology corporation, released its financial and operational results for the fiscal year ended December 31, 2017.

GTX Corp (GTXO) Issued New Patent and GPS SmartSoles Win Second Place in Tomorrow’s Care 2018 Awards

​GTX Corp (OTC: GTXO) announced today the issuance of U.S. patent 9,910,862.

Private Markets

iPRO Network, LLC

We provide the platform, tools, and resources to empower individuals and professionals to market desirable goods and services to the public, taking the place of traditional methods of commerce.